SCHEMBL6498508

SCHEMBL6498508

CSc1ccc(C=CC(=O)N2CCC(C(=O)NC(CNC(=O)c3cccc(F)c3)C(=O)O)CC2)c(Cl)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 9/20 0.45
ITGB2 P05107 8/20 0.45
ICAM1 P05362 8/20 0.45
CAPN1 P07384 4/20 0.40
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CCR1 P32246 1/20 0.36
CASP3 P42574 1/20 0.35
EPHX2 P34913 1/20 0.35
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498498 1.00 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6498494 1.00 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6500234 0.93 ITGAL (0.46) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6500228 0.93 ITGAL (0.46) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6495913 0.92 ITGAL (0.51) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL8297366 0.92 ITGAL (0.51) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6495908 0.92 ITGAL (0.51) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6497938 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6497930 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6497925 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed